Adaptive Biotechnologies Hits Day High with 8.36% Surge in Stock Price
Adaptive Biotechnologies Corp. has shown notable stock performance, with significant gains over the past month and year, outpacing the S&P 500. The company reported its highest quarterly net sales and reduced raw material costs, although it faces challenges with negative EBITDA and a high debt-to-equity ratio.
Adaptive Biotechnologies Corp. has experienced a significant uptick in its stock performance, gaining 8.36% on October 8, 2025. The stock reached an intraday high of USD 15.57, reflecting a strong day of trading for the small-cap company in the Pharmaceuticals & Biotechnology sector. Over the past month, Adaptive Biotechnologies has shown impressive growth, with a 24.0% increase compared to a modest 3.6% rise in the S&P 500. The company's one-year performance stands out, boasting a remarkable 196.19% gain, significantly outpacing the S&P 500's 17.88% increase during the same period.
Key financial metrics indicate a positive trend, with the company reporting its highest net sales of USD 58.88 million in the last quarter and a notable reduction in raw material costs by 32.22% year-over-year. Despite these achievements, the company is navigating a challenging landscape with a negative EBITDA and a high debt-to-equity ratio of -0.30.
Overall, Adaptive Biotechnologies Corp. continues to demonstrate strong market performance, particularly in the short and long term, while maintaining high institutional holdings at 100%.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
